相关实验视频

Updated: Jul 15, 2025

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies

The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies

Published on: February 12, 2015

针对PSMA进行成像和治疗的放射性标记单克隆抗体的现状

Mohammed Abusalem¹, Lucia Martiniova², Sarita Soebianto¹

¹Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

|September 28, 2023

概括

针对前列腺特异性膜抗原 (PSMA) 的放射标记单克隆抗体为前列腺癌 (PCa) 提供了先进的成像和治疗. 这些针对PSMA的药物对改善PCa男性的检测和治疗策略有很大的希望.

科学领域:

在瘤学瘤学.
放射化学放射化学是指辐射化学.
分子成像学分子成像学

背景情况:

前列腺癌 (PCa) 是全球男性的主要癌症诊断.
前列腺特异性膜抗原 (PSMA) 是PCa检测和治疗的关键分子标.
单克隆抗体 (mAbs) 为向癌症抗原提供高特异性.

研究的目的:

审查针对PSMA的放射性标记单克隆抗体 (mAbs) 的最新进展.
讨论这些药物在前列腺癌 (PCa) 成像和治疗中的前景.

主要方法:

关于放射性标记PSMA向单克隆抗体 (mAbs) 的最新文献的综述.
对mAbs (PET,SPECT,放射治疗) 的各种放射性核素标记技术的讨论.

主要成果:

针对PSMA的放射性标记mAbs越来越多地用于PCa中的分子成像和向治疗.
不同的放射性核化物可以与mAbs结合,用于各种应用,如PET成像或放射治疗.
针对PSMA的mAbs对癌细胞具有很高的特异性,可能减少副作用.

结论:

放射性标记PSMA向的mAbs代表了前列腺癌 (PCa) 管理的重大发展.
这些药物有望提高PCa患者的诊断准确性和治疗疗效.
对PSMA向放射性药物的进一步研究可能会扩大其临床实用性.

关键词:

在PSMA上,PSMA可以在PSMA上进行交易.影像成像技术影像成像技术前列腺癌是前列腺癌.标有放射性标记的mAbs 有针对性的放射性核酸治疗.

更多相关视频

Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens

Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens

Published on: June 23, 2022

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...